Hypothyroidism is a pathologic condition generated by the thyroid hormone deficiency. 
Introduction
Hypothyroidism is a pathologic condition generated by the thyroid hormone deficiency. The American Thyroid Association (ATA) advises for the screening of hypothyroidism beginning at 35 years and thereafter every 5 years in people at high risk for this condition: females older than 60 years, pregnant women, patients with other autoimmune disease or patients with a history of neck irradiation [1] .
Hypothyroidism in pregnant women can been associated with adverse effect in mother (anemia, congestive heart failure, pre-eclampsia, placental abnormalities, gestational diabetes), and child (low birth weight and disorders of neuropsychological development). These complications occur in women in most cases in situations with severe hypothyroidism. Women with mild hypothyroidism or subclinical hypothyroidism may have no symptoms. Studies on the prevalence of hypothyroidism in pregnancy provided quite different results. Thus, in a study including 500.000 pregnant women from the United States of America, Blatt AJ et al. report that the prevalence of hypothyroidism in pregnancy was 15.5% [2] . In an issue of the Journal of Obstetrics and Gynecology of India, published in 2014, Ajmani SN et al. analyzed the prevalence of overt and subclinical thyroid dysfunction in pregnancy in India. Overall 400 pregnant women with a gestational age between 13 and 26 weeks were included in the study. The prevalence of hypothyroidism was 12% [3] . The authors state that "The prevalence of thyroid disorders was high in our study with associated adverse maternal and fetal outcomes. Routine screening of thyroid dysfunction is recommended to prevent adverse fetal and maternal outcomes" [3] . In another article, Sahu et al reported a prevalence of overt and subclinical hypothyroidism of 6.47 %. The study was conducted over a period of three years and included 633 pregnant women [4] . Finally, in a prospective study conducted by Saraladevi R et al. that included 1000 pregnant women from the first trimester till delivery, the prevalence of subclinical hypothyroidism was 6.4% and of overt hypothyroidism was 2.8% [5] .
General considerations
Previous studies have shown that pregnancy generates increases in size of the thyroid gland and thyroid function changes [1, 6] [6] .
Changes in thyroid volume in regions with a sufficient iodine intake, is evaluated at 10%. The authors state that most of the modifications are represented by vascular thyroid swelling [7] . In regions with a lower iodine intake, changes in thyroid volume range between 20-35% [8, 9] . The World Health Organization (WHO), recommend a iodine intake for pregnant and lactating women of 250 µg per day [10] .
Dietary requirements of iodine in pregnant women are increased in comparison with non pregnant women. Iodine is involved in the following mechanisms:  Production of thyroid hormone increases by about 50% during pregnancy, starting during the first trimester, due to high human chorionic gonadotropin (HCG) and estrogen levels. HCG exhibits an action of thyroid stimulation and directly promotes the growth of the thyroid. In the same time, estrogens generate an increase "in the sialylation of thyroxine binding globulin (TBG), leading to reduced hepatic TBG clearance and increased concentrations of circulating TBG" [11] [12] [13] .  In the second half of pregnancy, the peripheral metabolism of thyroid hormones may be increased as a result of placental deiodination of thyroxine (T 4 ) to reverse triiodothyronine (rT 3 ) [14] .  Iodide transport from the maternal to the fetal circulation. Feto-maternal transfer of iodide is mediated by two transporters: the sodium-iodide symporter and Pendrin [15, 16] .  Early in the pregnancy there is an increase in the glomerular filtration which leads to an increase in iodide clearance from plasma [17] .
Management of hypothyroidism during pregnancy
The 4 ". The goal of treatment of maternal overt hypothyroidism is to bring back the serum TSH values to the reference range specific for the pregnancy trimester [1] . The same guide recommends treatment of maternal hypothyroidism with oral levothyroxine, also known as LT 4 Some studies highlight the association between subclinical hypothyroidism during pregnancy and increased risk for gestational diabetes, preterm delivery or pregnancy loss, hypertension or pre-eclampsia [21] [22] [23] [24] . The relationship between SCH and gestational diabetes mellitus (GDM) is not fully elucidated. There are studies that highlight the association between elevated TSH and risk of occurrence of GDM. Tudela CM et al., in an issue of the Obstetrics & Gynecology published in 2012 entitled "Relationship of subclinical thyroid disease to the incidence of gestational diabetes" report that "the likelihood of gestational diabetes increased with thyrotropin level". In this study were included 24.883 women, of which 95.5% were euthyroid, 2.3% had subclinical hyperthyroidism and 2% had subclinical hypothyroidism. In another study, Karakosta P et al. found that the high TSH in early pregnancy was associated with a 4-fold increased risk for GDM [25, 26] .
Several studies, but not all found an association between SCH in pregnancy and altered neuropsychological development of the [1, 18] . Recent advances in the field recommends considering LT 4 replacement in isolated maternal hypothyroxinaemia in the first trimester [18] . 
Conclusions
Hypothyroidism in pregnant women can been associated with adverse effect in mother and child. International guidelines recommend the treatment of maternal overt and subclinical hypothyroidism.
Currently the international guidelines recommend that isolated hypothyroxinemia in pregnancy should not be treated, but recent advances in the field recommends considering LT 4 replacement in isolated maternal hypothyroxinaemia in the first trimester.
